Research Directions | November 2023
23 November 2023Monthly insights on Australian and international MND research by our Executive Research Director, Dr Gethin Thomas – November 2023 edition.
Monthly insights on Australian and international MND research by our Executive Research Director, Dr Gethin Thomas – November 2023 edition.
MND Research Australia is thrilled to announce $3.1 million in research grants for projects commencing in 2024 ...
Recent media articles highlight the critical need for there to be absolute clarity between the States, Territories and the Commonwealth governments regarding the continuity of care of patient consumers with life limiting conditions ...
Monthly insights on Australian and international MND research by our Executive Research Director, Dr Gethin Thomas – October 2023 edition.
Monthly insights on Australian and international MND research by our Executive Research Director, Dr Gethin Thomas – September 2023 edition.
The PBAC is currently accepting submissions regarding the inclusion of Edaravone (RADICAVA®) on the Pharmaceutical Benefits Scheme.
We are excited to announce the recipients of the Daniel McLoone Major Research Initiative jointly funded by MND Research Australia (MNDRA) and FightMND.
The 2023 Clinical Research Learning Institute will be held on 13-14 October, 2023.
Monthly insights on Australian and international MND research by our Executive Research Director, Dr Gethin Thomas – August 2023 edition.
Recent media stories have highlighted a new clinical trial currently underway in Melbourne. The trial, for a drug called SPG302, is being run on behalf of Spinogenix ...